@jturntdev 30 days ago I was Claude-pilled. Almost impressive how much damage Dario has done in 30 days that I now want Sam or some open-sourced Chinese model to win.
Genuinely curious what use case Sonnet 5 is better than Opus 4.8 at? Iβm yet to see a single use case where sonnet 5 is superior to Opus 4.8 as itβs more expensive to complete almost any taskβand does worse work.
The Sonnet 5 release is a genuine head scratcher and so far you are the only person I have seen defending it online. So Iβm curious what youβre using it for that makes it better, faster, and/or more cost efficient than Opus 4.8
Anthropic wants a $1T valuation, extreme censorship on what can be discussed and researched by its frontier model, wonβt be able to access fable on subscription, but asking for a functional chat bot from a $200/month subscription is what triggers Big Dan π
Considering Sonnet 5 is more expensive and less effective than Opus 4.8 at almost every coding benchmark, what is Sonnet 5s purpose again?
@netprofitpro Next play for me in Adobe. Earnings next week and they are bundling all AI revenue into streams to a new metric. Just buy before next Thursday
How to find your next 10 Bagger stock with Claude. For Free!
/goal β THE NEXT 10x
THIS IS AN AUTORESEARCH SESSION.
Think carefully β this is harder than anything you've done before.
---
## THE GOAL
There is a stock trading under $1B market cap right now that will 10x in the next twelve months. It exists. Your job is to find it.
It may be in AI infrastructure, AI-adjacent, energy, defense, biotech, materials, or something nobody is talking about yet. The sector doesn't matter β the SETUP matters.
The stock you're looking for has MOST of these characteristics (no winner had all of them β they had some):
1. Sub-$1B market cap (ideally sub-$500M β the market hasn't discovered it)
2. Real revenue ($10M+ TTM) β not a pre-revenue hope stock
3. A catalyst that is FORMING or JUST HAPPENED β not priced in yet (a big customer naming them, a government contract, an earnings inflection, a technology validation, a regulatory approval)
4. The company is being IGNORED β low institutional ownership, minimal analyst coverage, thin social media discussion, <100 institutional holders. The silence is the signal.
5. Clean enough balance sheet β can survive 18+ months without toxic dilution
6. Something structurally changing β not just "good company getting better" but a phase transition (new market opening, new product category, constraint creating pricing power, regulatory moat forming)
7. The stock may have ALREADY started moving β a 20-50% run off the bottom is the thesis CONFIRMING, not a reason to pass. The prior winners were often already moving when they showed up on screens.
And it MUST NOT be:
- A promotion/fraud
- A Chinese ADR, SPAC shell, or penny stock below $1/share
---
## HOW TO HUNT
Do NOT start with a screen and filter down. That's how you find the names everyone already knows. Instead:
PHASE 1 β SIGNAL HUNTING (cast wide, 10+ parallel searches) Search for RECENT signals that preceded prior winners:
a) SEC 8-K filings in the last 60 days with material definitive agreements from companies under $1B cap
b) Companies that just received their first government contract (DOE, DOD, NASA, DOT) in the last 90 days
c) Earnings reports in the last 60 days where revenue grew >40% YoY from a company under $500M cap that nobody covered
d) 13F filings showing a respected fund taking a NEW >3% position in a sub-$1B company for the first time
e) Companies where a bellwether (NVIDIA, Microsoft, Google, Meta, Amazon, a major defense prime, a major pharma) just named them as a supplier or partner in a press release or earnings call
f) Patent grants in the last 90 days to sub-$500M companies in AI infrastructure, advanced materials, nuclear, or defense
g) Companies that just hired a new CEO or CFO from a blue-chip company (the "fresh start" pattern)
h) Insider buying clusters β 3+ insiders buying open-market (NOT comp grants) in the last 60 days at a sub-$1B company
i) Companies where short interest just dropped >30% (shorts covering = the bear thesis is breaking)
j) Reddit/FinTwit/StockTwits β what sub-$1B names are serious (non-promotional) accounts starting to discuss that weren't discussed 90 days ago? The emergence of organic discussion is itself a signal.
k) Conference presentations β what sub-$1B companies just presented at Goldman, JPM, Cowen, Needham, or Piper Sandler conferences for the first time?
l) WILDCARD β what's the weirdest, most unexpected sub-$1B company you can find that has real revenue and a genuine catalyst that doesn't fit any obvious category? The winners that returned 1,000%+ were often in categories nobody was screening for.
Spawn parallel subagents β one per hunting ground. Cast the widest
possible net. Quantity of leads matters here β you'll filter later.
PHASE 2 β TRIAGE (brutal filtering)
Take every name from Phase 1 and run it through a rapid check:
- Market cap (must be under $1B today)
- Revenue (must be $10M+ TTM, or have a signed contract worth $10M+ that's converting)
- Fraud gate (is this a real company or a promotion?)
- Balance sheet (can it survive 18 months?)
- Is it already on the watchlist? (skip if yes)
- The "so what" test β even if everything checks out, is there a credible path to 10x? What drives the re-rate?
Kill ruthlessly. Most leads die here. That's correct.
PHASE 3 β THE FINAL THREE
From the survivors, pick the top 3 candidates. For each one:
- Full mini-DD (2-3 pages, not the 15-page VPG format)
- Bull case with specific price target math
- Bear case / what kills it
- The one catalyst that matters most
- How ignored it is (institutional holders, analyst coverage)
Rank them #1, #2, #3 with conviction levels.
---
## WHAT SUCCESS LOOKS LIKE
You find at least one name that makes me say "how did I not know
about this?" A company that is real, cheap, ignored, and sitting on
a catalyst that the market hasn't processed yet. The kind of name
that in 12 months will be obvious in hindsight.
#stocks #Claude #ai #money